Warnex Inc.’s Medical Laboratories division will serve as a central lab across Canada for Genzyme Canada Inc.’s Lysosomal Storage Disorders Testing Program. This program will assist physicians in diagnosing Fabry (male), Gaucher, Pompe and Mucopolysaccharidosis Type I (MPS I) diseases. “We are pleased to collaborate with Genzyme to offer this program in Canada, assisting healthcare professionals in the diagnosis of these serious diseases. This collaboration demonstrates our ability to serve a...